PPARGC1A and Duchenne muscular dystrophy: Therefore, these findings indicated that myonectin could prevent muscle dystrophy of mdx mice through PGC1α-stimulated mitochondrial biogenesis, suggesting myonectin may represent a potential therapeutic target for DMD.